|
||||||||||||||||
|
||||||||||||||||
|
Nursing Leadership in Global and Domestic Tobacco ControlTobacco use and exposure to tobacco smoke are known human carcinogens and have contributed to a global epidemic and public health emergency. Tobacco continues to be the leading cause of preventable death and illness in the United States and the second-leading cause in the world (U.S. Department of Health and Human Services, 2004; World Health Organization [WHO], 2008b). Tobacco is responsible for one in three cancer deaths in the United States. Prevention of tobacco-related disease, disability, and death could be achieved through the promoting of tobacco control: preventing uptake, helping smokers quit, and preventing exposure to secondhand smoke. Nurses can effectively deliver evidence-based interventions for tobacco dependence that significantly reduce tobacco use (Rice & Stead, 2008). Nursing involvement in community action, helping patients quit, promoting an environment free of tobacco smoke, and supporting effective tobacco control policies is essential to solve this problem (Sarna, Bialous, Barbeau, & McLellan, 2006). Nurses must provide leadership in these efforts (Malone, 2006; Sarna & Bialous, 2005), along with other healthcare professionals. Worldwide, more than 1 billion people smoke (WHO, 2008a), 1 of 10 youths smoke, and 50% of youths are exposed to tobacco smoke in public places (Warren, Jones, Eriksen, & Asma, 2006). Five million tobacco-related deaths occur every year. If trends continue, by 2030 more than 8 million people will die annually because of tobacco use; 80% in developing countries (WHO, 2008b). To address this epidemic, WHO initiated the first international, legally binding treaty focusing on a public health problem: the WHO Framework Convention on Tobacco Control (FCTC). More than 150 countries have ratified the WHO (2008a) FCTC. The treaty calls for restrictions on tobacco advertising, promotion, and sponsorship; tobacco smuggling control; a ban on misleading tobacco descriptors such as “low tar,” “light,” and “mild”; protection from secondhand smoke; cessation treatment for tobacco users, and prominent pictorial health warnings on tobacco products. Recently, WHO launched policy recommendations that will facilitate the implementation of the WHO (2008b) FCTC. It provides guidance to countries on increasing tobacco product taxes, preventing exposure to tobacco smoke and providing cessation services, among other policy recommendations. Nurses worldwide have been involved in efforts to ensure that these policies are adopted, but further efforts are needed. Global action is essential because tobacco-induced death and disability is predicted to increase in countries with limited healthcare resources. Efforts in the United States also are central to reducing the risk to Americans, especially youth and underserved populations. Health disparities exist in tobacco-related conditions, such as increased risk for cancer among certain ethnic minorities and those with lower socioeconomic status and decreased access to health services (U.S. Department of Health and Human Services, 2004). Patients who smoke often are blamed unfairly or blame themselves for causing a tobacco-related cancer. In fact, many became addicted to nicotine in their adolescence or youth by an industry that spends billions of dollars to promote a product that, if used as directed, kills up to 50% of its users. Nurses must actively engage in efforts to diminish this stigma. Tobacco dependence is a chronic condition that requires ongoing treatment (Steinberg, Schmelzer, Richardson & Foulds, 2008). The tobacco industry has been found guilty of hiding evidence from the public and obfuscating science and scientists (U.S. District Court for the District of Columbia, 2006), and calls have been made for professional organizations and academic centers to refuse to accept tobacco industry funding for research or services. Given the enormous public health cost of tobacco use—more than $100 billion per year—federal spending on efforts to reduce tobacco use and address tobacco-related diseases is severely underfunded (Gritz, Sarna, Dresler, & Healton, 2007). Nursing research in the area of tobacco control and tobacco dependence treatment can contribute significantly to developing interventions for all persons who smoke, including people with a cancer diagnosis (Cooley, Sipples, Murphy, & Sarna, 2008; Sarna & Bialous, 2006), but more efforts and support are needed to enhance the science in this area. The Oncology Nursing Society (ONS) acknowledges and is committed to maximizing the potential that nurses, the largest group of healthcare professionals, have in reducing adult and youth tobacco use, promoting cessation, actively protecting all people against secondhand tobacco smoke, and helping to increase access to tobacco use prevention and cessation services. In addition to the prevention of tobacco use to reduce cancer risk, intervention is needed to support the cessation efforts of patients with cancer and cancer survivors who are at increased risk for side effects of treatment, cancer recurrence, a second tobacco-related cancer, increased morbidity, decreased survival, and diminished quality of life. It Is the Position of ONS That
Advocacy All nurses and nursing organizations are actively involved in developing and supporting local, state, and national legislative and regulatory efforts that
Treatment
Public Education
Professional Education
Research
Furthermore, ONS Recommends That
References Cooley, M.E., Sipples, R.L, Murphy, M., & Sarna, L. (2008). Smoking cessation and lung cancer: Oncology nurses can make a difference. Seminars in Oncology Nursing, 24(1), 6–26. Gritz, E.R., Sarna, L., Dresler, C., & Healton, C.G. (2007). Building a united front: Aligning the agendas for tobacco control, lung cancer research, and policy. Cancer Epidemiology, Biomarkers, and Prevention, 16(5), 859–863. Malone, R.E. (2006). Nursing’s involvement in tobacco control: Historical perspective and vision for the future. Nursing Research, 55(4, Suppl), S51–S57. Rice, V.H., Stead, L.F. (2008). Nursing interventions for smoking cessation. Cochrane Database of Systematic Reviews, 1, CD001188. Sarna, L., & Bialous, S. (2005). Tobacco control in the 21st century: A critical issue for the nursing profession. Research in Theory and Nursing Practice, 19(1), 15–24. Sarna, L., Bialous, S., Barbeau, E., & McLellan, D. (2006). Strategies to implement tobacco control policy and advocacy initiatives. Critical Care Nursing Clinics of North America, 18(1),113–122. Sarna, L., & Bialous, S.A. (2006). Strategic directions for nursing research in tobacco dependence. Nursing Research, 55(4, Suppl.), S1–S9. Steinberg, M.B., Schmeizer, A.C., Richardson, D.L., & Foulds, J. (2008). The case for treating tobacco dependence as a chronic disease. Annals of Internal Medicine, 148(7), 554–556. U.S. Department of Health and Human Services. (2000). Healthy people
2010: What are the leading health indicators? Retrieved May 25, U.S. Department of Health and Human Services. (2004). The health consequences of smoking: A report of the surgeon general. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. U.S. Department of Health and Human Services. (2008). Treating tobacco use and dependence: 2008 update. Rockville, MD: Author. U.S. District Court for the District of Columbia. (2006). United States of America v. Philip Morris U.S.A., Inc. Retrieved August 12, 2008, from http://www.library.ucsf.edu/tobacco/litigation/usvpm/FinalOpinion_full_version.pdf Warren, C.W., Jones, N.R., Eriksen, M.P., & Asma, S. (2006). Patterns of global tobacco use in young people and implications for future chronic disease burdgen in adults. Lancet, 367(9512), 749–753. World Health Organization. (2008a). The WHO framework convention on tobacco control. Retrieved April 17, 2008, from http://www.who.int/tobacco/en World Health Organization. (2008b). WHO report on the global tobacco epidemic, 2008: The MPOWER package. Geneva, Switzerland: Author. Approved by the ONS Board of Directors 3/99; revised 5/00, 10/02, 4/05, 7/08; endorsed by the American Nurses Association, 12/08 |
|||||||||||